SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020)
SOPHiA GENETICS (SOPH) reported Non-Current Deffered Revenue of $142000.0 for Q4 2020.
SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020) Analysis & Trends
SOPHiA GENETICS (SOPH) has 1 years of Non-Current Deffered Revenue data on file, last reported at $142000.0 in Q4 2020.
- For the quarter ending Q4 2020, Non-Current Deffered Revenue changed N/A year-over-year to $142000.0; the trailing twelve-month figure through Dec 2020 stood at $142000.0 (changed N/A YoY), and the FY2020 full-year result was $142000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue held at $142000.0 in Q4 2020.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $142000.0 in Q4 2020 to a low of $142000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.43 Bn | 24.12 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.97 Bn | 14.07 Bn | 482.22 Mn | 4.57 Mn |
| 3 | Healthequity | 8.13 Bn | 7.86 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 5.98 Bn | 5.44 Bn | 106.18 Mn | 10.14 Mn |
| 5 | Hinge Health | 5.96 Bn | 5.64 Bn | 154.23 Mn | - |
| 6 | Waystar Holding | 4.43 Bn | 4.37 Bn | 216.84 Mn | 5.16 Mn |
| 7 | MiniMed | 4.38 Bn | 4.08 Bn | 480.00 Mn | - |
| 8 | Doximity | 3.91 Bn | 3.16 Bn | 125.97 Mn | 400,000.00 |
| 9 | Privia Health | 3.19 Bn | 2.77 Bn | - | - |
| 10 | SOPHiA GENETICS | 392.07 Mn | 321.78 Mn | 14.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 142,000.00 |